[HTML][HTML] Asplenia and spleen hypofunction

MV Lenti, S Luu, R Carsetti, F Osier… - Nature Reviews …, 2022 - nature.com
Asplenia (the congenital or acquired absence of the spleen) and hyposplenism (defective
spleen function) are common causes of morbidity and mortality. The spleen is a secondary …

[HTML][HTML] Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy

ZL Brumme, F Mwimanzi, HR Lapointe, PK Cheung… - npj Vaccines, 2022 - nature.com
Humoral responses to COVID-19 vaccines in people living with HIV (PLWH) remain
incompletely characterized. We measured circulating antibodies against the SARS-CoV-2 …

[HTML][HTML] Insights into induction of the immune response by the hepatitis B vaccine

FA Di Lello, AP Martínez… - World Journal of …, 2022 - ncbi.nlm.nih.gov
After more than four decades of hepatitis B virus (HBV) vaccine implementation, its safety
and efficacy in preventing HBV infection have been proven and several milestones have …

Impaired antibody response to COVID-19 vaccination in advanced HIV infection

N Hassold, S Brichler, E Ouedraogo, D Leclerc… - Aids, 2022 - journals.lww.com
Objectives: Coronavirus disease 2019 (COVID-19) vaccination is reportedly efficient in
people with HIV (PWH) but vaccine trials included participants with normal CD4+ T-cell …

[HTML][HTML] Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study

LC Netto, KY Ibrahim, CM Picone, APPS Alves… - The Lancet …, 2022 - thelancet.com
Background People living with HIV might have a poor or delayed response to vaccines,
mainly when CD4 cell counts are low, and data concerning COVID-19 vaccines in this …

[HTML][HTML] Anti-spike antibodies and neutralising antibody activity in people living with HIV vaccinated with COVID-19 mRNA-1273 vaccine: a prospective single-centre …

A Lombardi, GM Butta, L Donnici, G Bozzi… - The Lancet Regional …, 2022 - thelancet.com
Background Vaccines against COVID-19 are a powerful tool to control the current SARS-
CoV-2 pandemic. A thorough description of their immunogenicity among people living with …

Limited humoral and specific T-cell responses after SARS-CoV-2 vaccination in PWH with poor immune reconstitution

S Benet, O Blanch-Lombarte… - The Journal of …, 2022 - academic.oup.com
Background We analyzed humoral and cellular immune responses induced by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccines in …

[HTML][HTML] Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV

A Corma-Gómez, M Fernández-Fuertes… - Clinical Microbiology …, 2022 - Elsevier
Objectives The aim of this study was to assess the immunogenicity of SARS-CoV-2 available
vaccines among people living with HIV (PLWH) after a complete vaccination scheme, and …

[HTML][HTML] People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose …

HR Lapointe, F Mwimanzi, PK Cheung, Y Sang… - medRxiv, 2022 - ncbi.nlm.nih.gov
Background: Longer-term humoral responses to two-dose COVID-19 vaccines remain
incompletely characterized in people living with HIV (PLWH), as do initial responses to a …

[HTML][HTML] Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV

A Vergori, A Cozzi Lepri, S Cicalini, G Matusali… - Nature …, 2022 - nature.com
In order to investigate safety and immunogenicity of SARS-CoV-2 vaccine third dose in
people living with HIV (PLWH), we analyze anti-RBD, microneutralization assay and IFN-γ …